Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
Source: SeekingAlpha
2026-05-20 14:00:56 ET
Evogene Ltd. (EVGN) Q1 2026 Earnings Call May 20, 2026 9:00 AM EDT
Company Participants
Ofer Haviv - CEO, President & Director
Gabi Tarcic - Chief Development Officer
Dan Gelvan - Chief Executive Officer of Ag Plenus Ltd.
Polina Ravzin - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Evogene Ltd. (EVGN) Q1 2026 Earnings Call Transcript
Evogene Ltd.
NASDAQ: EVGN
EVGN Trading
-13.04% G/L:
$0.5461 Last:
344,916 Volume:
$0.6249 Open:
EVGN Latest News
July 08, 2026 07:00:00 am
Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery
June 24, 2026 08:00:00 am
Evogene Announces Major Milestone in Its Collaboration with Google Cloud, Advancing ChemPass AI(TM) Toward Autonomous Small Molecule Discovery and Optimization
June 09, 2026 07:00:00 am
Evogene to Present Its Pharma Division Achievements at the BIO International Convention
$6,644,881
6,267,035
N/A
7
N/A
Biotechnology & Life Sciences
Healthcare
IL
Rehovot
